{
    "title": "Reprocessed Single Use Medical Device Patient Safety Act of 1999",
    "content": "SECTION 1. SHORT TITLE.\n\n    This title may be cited as the ``Reprocessed Single Use Medical \nDevice Patient Safety Act of 1999''.\n\nSEC. 2. REPROCESSED MEDICAL DEVICES.\n\n    Subchapter A of chapter V of the Federal Food, Drug, and Cosmetic \nAct (21 U.S.C. 351 et seq.) is amended by adding at the end the \nfollowing:\n\n``SEC. 524. REPROCESSED MEDICAL DEVICES.\n\n    ``(a) Findings.--Congress makes the following findings:\n            ``(1) The Food and Drug Administration has information \n        indicating that some reprocessed medical devices labeled for \n        single use have been associated with serious injury and that \n        reprocessed medical devices labeled for single use have the \n        potential to cause injury.\n            ``(2) Reprocessed medical devices labeled for single use \n        are being used on patients without their knowledge, against \n        original manufacturers' warnings, and without a determination \n        by the Food and Drug Administration that such devices are safe \n        and effective.\n            ``(3) The reprocessing of devices that are labeled for \n        single use is currently occurring without premarket approval by \n        or notification to the Food and Drug Administration, such as is \n        required for certain devices under sections 510 and 515.\n            ``(4) The Food and Drug Administration should have the \n        knowledge and expertise to evaluate the safety and \n        effectiveness of reprocessed medical devices labeled for single \n        use.\n            ``(5) Enforcement by the Food and Drug Administration of \n        the provisions of this Act that address the safety and \n        effectiveness of devices is the only effective way to protect \n        patients exposed to reprocessed medical devices labeled for \n        single use.\n            ``(6) The United States public deserves to know that all \n        devices regulated by the Food and Drug Administration are safe \n        and effective and that the appropriate level of oversight is \n        being implemented in order to guarantee such safety and \n        effectiveness.\n    ``(b) Purpose.--The purpose of this section is to--\n            ``(1) require that the Food and Drug Administration \n        implement and enforce all provisions of this Act that are \n        applicable to reprocessed medical devices, including device \n        registration, listing, and premarket safety controls; and\n            ``(2) require the informed consent of patients prior to \n        using reprocessed class II, class III, and critical class I \n        medical devices.\n    ``(c) Registration.--Every person or establishment engaged in the \nreprocessing of a device labeled for single use shall--\n            ``(1) upon first engaging in the reprocessing of such \n        device, register with the Secretary and provide all information \n        required in accordance with section 510(c);\n            ``(2) for each year in which the person or establishment \n        engages in the reprocessing of such device, register with the \n        Secretary and provide all information required under section \n        510(b); and\n            ``(3) for each year in which the person or establishment \n        engages in the reprocessing of such device, submit to the \n        Secretary a list of devices labeled for single use that the \n        person or establishment is reprocessing, including the names of \n        the original equipment manufacturers of such devices and the \n        specific models of such devices that are reprocessed.\n    ``(d) Information.--Every person or establishment engaged in the \nreprocessing of a device labeled for single use shall, for each \nreprocessed medical device, provide to each person or establishment \nthat uses such reprocessed medical device, information necessary for \nsuch person or establishment to comply with subsection (f).\n    ``(e) Safety and Effectiveness.--Not later than 6 months after the \ndate of enactment of this section, every person or establishment \nrequired to register under subsection (c) with respect to a device \nshall, before introducing into interstate commerce a reprocessed \nmedical device labeled for single use, meet the requirements of \nsections 510(k) and 515 to demonstrate to the Secretary that such \nreprocessed device is safe and effective or substantially equivalent to \na device the Secretary has deemed safe and effective.\n    ``(f) Informed Patient Consent and Medical Records.--\n            ``(1) In general.--Every person or establishment that uses \n        a class II, class III, or critical class I reprocessed medical \n        device to provide medical care to an individual shall seek \n        informed consent from the patient for the use of such a device.\n            ``(2) Medical records.--\n                    ``(A) In general.--Every person or establishment \n                that uses a class II, class III, or critical class I \n                reprocessed medical device to provide medical care to \n                an individual shall keep a record of such use and \n                include a note of such use in such individual's medical \n                record.\n                    ``(B) Contents.--The contents of the record \n                described in paragraph (1) shall include--\n                            ``(i) the name and place of business of the \n                        person or establishment that reprocessed the \n                        device labeled for single use and the batch or \n                        lot number of such device; and\n                            ``(ii) the identity of the original \n                        manufacturer of the device.\n    ``(g) Report.--Not later than 9 months after the date of enactment \nof this section, the Secretary shall submit a report to the Committee \non Commerce of the House of Representatives and the Committee on \nHealth, Education, Labor, and Pensions of the Senate that describes \nfindings from current Food and Drug Administration studies (as of the \ndate of submission) on the safety and efficacy of reprocessing of \ndevices labeled for single use.\n    ``(h) Medwatch.--Not later than 6 months after the date of  \nenactment of this section, the Secretary shall modify the MEDWATCH \nforms to facilitate reporting of information relating to reprocessed \nmedical devices, including the name of a reprocessor and the number of \ntimes a device has been reused.\n    ``(i) Application.--All other sections of this Act that govern \ndevices as defined in section 201(h) shall also apply to reprocessed \nmedical devices, if applicable.\n    ``(j) Definitions.--In this section:\n            ``(1) Critical class i medical device.--The term `critical \n        class I medical device' means a device that may break the \n        mucosal boundary, may be introduced in the bloodstream, or may \n        be introduced into other than normally sterile areas of the \n        body.\n            ``(2) Reprocessed medical device.--The term `reprocessed \n        medical device' means a device that--\n                    ``(A) is labeled for single use, or is disposable \n                and intended for single use; and\n                    ``(B) is cleaned or sanitized after use in order \n                that such a device may be reused upon another \n                individual.\n            ``(3) Reprocessing.--The term `reprocessing' means a \n        procedure employed in order to produce a reprocessed medical \n        device.''."
}